Nisa Investment Advisors’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,330
Closed -$453K 2195
2019
Q4
$453K Buy
5,330
+2,430
+84% +$162K ﹤0.01% 1124
2019
Q3
$145K Buy
2,900
+2,540
+706% +$101K ﹤0.01% 1396
2019
Q2
$13K Hold
360
﹤0.01% 1703
2019
Q1
$10K Sell
360
-9,035
-96% -$213K ﹤0.01% 1772
2018
Q4
$180K Sell
9,395
-7,300
-44% -$170K ﹤0.01% 1269
2018
Q3
$499K Buy
16,695
+8,915
+115% +$336K ﹤0.01% 1095
2018
Q2
$286K Sell
7,780
-3,000
-28% -$97.5K ﹤0.01% 1188
2018
Q1
$331K Hold
10,780
﹤0.01% 1128
2017
Q4
$295K Buy
10,780
+2,300
+27% +$70.8K ﹤0.01% 1176
2017
Q3
$314K Hold
8,480
﹤0.01% 1145
2017
Q2
$336K Sell
8,480
-1,000
-11% -$44.5K ﹤0.01% 1121
2017
Q1
$464K Buy
9,480
+580
+7% +$26.5K 0.01% 1051
2016
Q4
$302K Hold
8,900
﹤0.01% 1163
2016
Q3
$336K Hold
8,900
﹤0.01% 1110
2016
Q2
$299K Buy
8,900
+3,000
+51% +$106K ﹤0.01% 1134
2016
Q1
$187K Hold
5,900
﹤0.01% 1228
2015
Q4
$220K Sell
5,900
-1,100
-16% -$41.6K ﹤0.01% 1167
2015
Q3
$281K Hold
7,000
﹤0.01% 1126
2015
Q2
$200K Buy
+7,000
New +$195K ﹤0.01% 1251
2014
Q1
Sell
-6,100
Closed -$236K 1349
2013
Q4
$236K Hold
6,100
﹤0.01% 1235
2013
Q3
$204K Buy
+6,100
New +$194K ﹤0.01% 1249

Other funds holding MDCO

Nisa Investment Advisors's MDCO Position: Q1 2020 in Review

Nisa Investment Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 5,330 shares — an estimated $453K sold.

Nisa Investment Advisors first reported a position in MDCO in Q3 2013 and held it in 21 quarters. The position peaked at $499K in Q3 2018. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Nisa Investment Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Nisa Investment Advisors sold 5,330 Medicines Co shares in Q1 2020, an estimated $453K.
  • Nisa Investment Advisors first reported a position in Medicines Co in Q3 2013 and held it in 21 quarters.
  • Nisa Investment Advisors's Medicines Co position peaked at $499K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Nisa Investment Advisors's 13F filing for Q1 2020, filed 17 Apr 2020.